Skip to main content
  • Book
  • © 2006

Stem Cells

Part of the book series: Handbook of Experimental Pharmacology (HEP, volume 174)

Buy it now

Buying options

eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

This is a preview of subscription content, log in via an institution to check for access.

Table of contents (16 chapters)

  1. Front Matter

    Pages I-XI
  2. Cardiac Repair by Embryonic Stem-Derived Cells

    • M. Rubart, L.J. Field
    Pages 73-100
  3. Cardiomyocytes from Human Embryonic Stem Cells

    • R. Passier, C. Denning, C. Mummery
    Pages 101-122
  4. Therapeutic Potential of Stem Cells in Diabetes

    • E. Roche, R. Enseñat-Waser, J.A. Reig, J. Jones, T. León-Quinto, B. Soria
    Pages 147-167
  5. The Stem Cell Continuum: A New Model of Stem Cell Regulation

    • P.J. Quesenberry, G.A. Colvin, M.S. Dooner
    Pages 169-183
  6. Markers of Adult Tissue-Based Stem Cells

    • M.R. Alison, M. Brittan, M.J. Lovell, N.A. Wright
    Pages 185-227
  7. Mesenchymal Stem Cells: Isolation, In Vitro Expansion and Characterization

    • N. Beyer Nardi, L. da Silva Meirelles
    Pages 249-282
  8. Back Matter

    Pages 409-414

About this book

Signi?cant advances in stem cell research and their potentials for therap- tic applications have attracted the attention of the scienti?c community and captured the imagination of society as a whole. Not so long ago, the study of most stem cells, other than those that regenerated the haematopoietic system, was rather obscure and limited to a relatively small number of researchers and laboratories. The uproar over stem cells really began in 1998 with the s- cessful derivation of pluripotent human embryonic stem (ES) cells by James Thomson and co-workers. This breakthrough and the subsequent generation of specialized human cells in vitro led to a paradigm shift within the sci- ti?c community, which transformed this specialized endeavour from a topic of scienti?c interest to a line of investigation with the potential to generate cells - pable of treating serious ailments, including diabetes, cardiovascular diseases and neurodegenerative disorders. Thus the dawn of regenerative medicine has spawned from the somewhat esoteric study of stem cells. Since 1998, extensive research endeavours have been devoted to the study of both embryonic and adult stem cells. Early reports suggested that adult stem cells had a higher plasticity than previously believed, perhaps even comparable with that demonstrated by embryonic stem cells, but several observations of the so-called transdifferentiation capacity and plasticity of adult stem cells have not been repeated. These reports, however, encouraged on-going debates about the capacity of adult versus embryonic stem cells and their potential use in regenerative medicine.

Editors and Affiliations

  • In Vitro Differentiation Group, Dept. of Cytogenetics, Leibnitz Institute of Plant Genetics and Crop Plant Research (IPK), Gatersleben, Germany

    Anna M. Wobus

  • Laboratory of Cardiovascular Science, Gerontology Research Program, National Institute on Aging, NIH, Baltimore, USA

    Kenneth R. Boheler

Bibliographic Information

Buy it now

Buying options

eBook USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access